These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2422473)

  • 21. Arrhythmia and acute coronary syndrome suppression and cardiac resuscitation management with bretylium.
    Bacaner M; Dembo DH
    Am J Ther; 2009; 16(6):534-42. PubMed ID: 19542875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
    Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves.
    Ross SB; Gosztonyi T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):283-93. PubMed ID: 1161049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM; Kagan K; Hibser NK
    Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The actions of bretylium: adrenergic neurone blocking and other effects.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1959 Dec; 14(4):536-48. PubMed ID: 13803290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitiative comparison of bretylium with other antifibrillatory drugs.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):504-12. PubMed ID: 5650730
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of bretylium on the subcellular distribution of noradrenaline and on adrenergic nerve function in rat heart.
    Abbs ET; Pycock CJ
    Br J Pharmacol; 1973 Sep; 49(1):11-22. PubMed ID: 4787519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
    Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
    Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of bretylium in prehospital ventricular fibrillation.
    Harrison EE; Amey BD
    Am J Emerg Med; 1983 Jul; 1(1):1-6. PubMed ID: 6680596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bretylium tosylate for suppression of induced ventricular fibrillation.
    Bacaner M
    Am J Cardiol; 1966 Apr; 17(4):528-34. PubMed ID: 5929660
    [No Abstract]   [Full Text] [Related]  

  • 33. Sodium sensitive active transport of bretylium into adrenergic neurons for the development of blockade in rabbit ileum.
    Hosotani T; Misu Y
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):235-45. PubMed ID: 879907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrillatory drugs: the case for bretylium tosylate.
    Dronen SC
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):805-7. PubMed ID: 6476547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenergic mechanisms in postvagal tachycardia.
    Loeb JM; Vassalle M
    J Pharmacol Exp Ther; 1979 Jul; 210(1):56-63. PubMed ID: 448648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antagonism of adrenergic neurone blockade by amphetamine and dexamphetamine in the rat and guinea-pig.
    Follenfant MJ; Robson RD
    Br J Pharmacol; 1970 Apr; 38(4):792-801. PubMed ID: 5441791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects on renal sympathetic axons in dog of acute 6-hydroxydopamine treatment in combination with selective neuronal uptake inhibitors.
    Sunn N; Harris PJ; Bell C
    Br J Pharmacol; 1990 Apr; 99(4):655-60. PubMed ID: 2141795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bretylium in hypothermia-induced ventricular fibrillation in dogs.
    Elenbaas RM; Mattson K; Cole H; Steele M; Ryan J; Robinson W
    Ann Emerg Med; 1984 Nov; 13(11):994-9. PubMed ID: 6486552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.